NACDS: “The Congress and states need no further validation for their bipartisan work to immediately confront pharmaceutical benefit manipulation that is devastating Americans, communities, and pharmacies of all sizes.” ARLINGTON, Va., July 9, 2024 /PRNewswire-PRWeb/ — National…
NACDS: Initial Findings of FTC’s PBM Study Demand Action
This post was originally published on this site